Monthly roundup: Why is SMT popular, can biotech M&A continue and who thinks it’s an AI bubble?

Jo, Ryan and David discuss the latest news and results in the investment trust world. Click here to read more: https://tinyurl.com/bd9c8ay5 

 

Editor's Picks

Loading...